Concepedia

Hitoshi Yoshiji

HY

Statistics

Publications

259

Citations

13.9K

H-Index

55

Active since

1990

Affiliations

Nara Medical University(Current)

Kagawa University

The University of Tokyo

Ehime University

Musashino Red Cross Hospital

Hitoshi Yoshiji is an author at Nara Medical University specializing in medicine, liver disease, and pharmacology.

ORCID

Publications per year

1990–2025

258

Publications

259

Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.

Daniel E. Gómez, Daniel F. Alonso, Hitoshi Yoshiji et al. · PubMed · 1997 · 1.5K citations

, , +9

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii et al. · Hepatology · 2001 · 383 citations

, , +16

Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer.

Hitoshi Yoshiji, Daniel E. Gómez, Masabumi Shibuya et al. · PubMed · 1996 · 374 citations

, , +16

Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis

Hitoshi Yoshiji · Gut · 2003 · 301 citations · Full text

, , +16

Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect <i>in vivo</i>

Satoshi Yasuda, Masayuki Sho, Ichiro Yamato et al. · Clinical & Experimental Immunology · 2013 · 281 citations · Full text

, , +17

1–5 of 259